Error: Could not add to watchlist. X
+ Watchlist

Novus Therapeutics Inc

2TKA:GR
Munich
3.26
EUR
0.00
0.00%
As of 9:41 AM EDT 8/18/2017
Volume
400
Previous Close
3.26
52Wk Range
3.06 - 15.53
1 Yr Return
-63.19%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
400
Previous Close
3.26
52Wk Range
3.06 - 15.53
1 Yr Return
-63.19%
YTD Return
-58.71%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
22.655
Shares Outstanding (m)
6.943
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.41%
% Price Change
-0.38%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Novus Therapeutics, Inc. operates as a pharmaceutical company. The Company provides acquisition, development, and commercialization of medicinal products for ear, nose, and throat disorders. Novus Therapeutics serves customers in the United States.
Address
19900 MacArthur Blvd
Suite 550
Irvine, CA 32612
United States
Phone
1-949-238-8090
Show More